Induced pluripotent stem cells in hematology: current and future applications.
Blood Cancer J
; 4: e211, 2014 May 09.
Article
em En
| MEDLINE
| ID: mdl-24813079
ABSTRACT
Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Células-Tronco Pluripotentes Induzidas
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Blood Cancer J
Ano de publicação:
2014
Tipo de documento:
Article
País de afiliação:
Itália